CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
138 hedge funds and large institutions have $2.08B invested in China Biologic Products Holdings, Inc. in 2016 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 35 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $2.15B → $2.08B (-$74.6M)
4% less call options, than puts
Call options by funds: $19.3M | Put options by funds: $20M
Holders
138
Holding in Top 10
7
Calls
$19.3M
Puts
$20M
Top Buyers
| 1 | +$155M | |
| 2 | +$96.2M | |
| 3 | +$36.2M | |
| 4 |
Ninety One (UK)
London,
United Kingdom
|
+$19.3M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
+$15.3M |
Top Sellers
| 1 | -$295M | |
| 2 | -$55.5M | |
| 3 | -$22.3M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$20.1M |
| 5 |
Renaissance Technologies
New York
|
-$15M |